Using a robotic seal to improve quality of life for dementia patients
Official title: PARO: Psycho-social Intervention With Paro Robotic Seal Focused on Patients With Dementia
Run by Istituto Nazionale di Ricovero e Cura per Anziani · NCT05626205 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether a robotic seal can help improve the mood and overall quality of life for elderly people with dementia when used alongside regular treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Istituto Nazionale di Ricovero e Cura per Anziani Academic / other |
| Locations | 1 site (Ancona) |
| Trial ID | NCT05626205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly individuals diagnosed with mild to moderate dementia who have been attending the Alzheimer's Day Center for at least three months.
✕Probably not a fit
Patients with severe sensory disabilities, comprehension difficulties, or uncontrolled severe behavioral syndromes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates how the Paro robotic seal can enhance the quality of life for elderly patients with dementia when integrated with traditional interventions. It focuses on measuring improvements in cognitive status, mood, and technology acceptance among participants. Various assessment tools, including the Quality of Life - Alzheimer's Disease scale and the Addenbrooke's Cognitive Examination, will be utilized to gather data on patient outcomes. The study is conducted at the IRCCS INRCA Alzheimer's Day Center, where patients interact with the robot under the supervision of caregivers.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life for patients with dementia.
How similar studies have gone: Other studies have shown promise in using technology-based interventions for dementia, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of mild-moderate dementia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM V). * MMSE between 10 and 24 * Attending the Alzheimer's Day Center since at least 3 months * Presence of a caregiver Exclusion Criteria: * Severe sensory disabilities (visual and auditory) * Comprehension difficulties * History of syncopal episodes, epilepsy, and dizziness not controlled pharmacologically * Severe autonomic system dysfunction * Severe behavioral syndromes not compensated by medication
Where it's running
-
IRCCS INRCA Hospital
Ancona, Italy Recruiting
Study contacts
- Principal investigator: Roberta Bevilacqua — Irccs Inrca
- Study coordinator: Anna Rita Bonfigli
- Email: a.bonfigli@inrca.it
- Phone: 00390718003719
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
-
Testing LY4405094 in healthy people and people with Alzheimer’s disease
This study tests LY4405094 to see if it is safe and how it behaves in the body, including how it reaches the brain fluid in healthy participants and how it affects a brain protein in people with Alzheimer's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.